Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer

Diagnostic Pathology

Volumn 9, Issue 1, 2014, Pages

  Liu, Jiannan ^a,b   Liu, Chuanyong ^a   Qiu, Liyun ^a   Li, Juan ^a   Zhang, Pei ^a   Sun, Yuping ^a  

^a SHANDONG UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Lymphatic micro vessel density; Non small cell lung cancer; Platelet derived growth factor BB; Vascular endothelial growth factor C

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; TUMOR MARKER; VASCULOTROPIN C; VEGFC PROTEIN, HUMAN;

AGED; CHEMISTRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; UPREGULATION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-SIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84902923393     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-9-128     Document Type: Article

References (36)

1. She J, Yang P, Hong Q, Bai C. Lung cancer in china: challenges and interventions. Chest 2013, 143(4):1117-1126.
2. Lu Q, Lu S, Huang L, Wang T, Wan Y, Zhou C, Zhang C, Zhang Z, Li X. The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer. Diagn Pathol 2013, 8:145.
3. Pfannschmidt J, Muley T, Bülzebruck H, Hoffmann H, Dienemann H. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. Lung Cancer 2007, 55(3):371.
4. Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R, Sohara Y, Miya T, Miyaoka E. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005, 50(2):227-234.
5. Christiansen A, Detmar M. Lymphangiogenesis and cancer. Genes Cancer 2011, 2(12):1146-1158.
6. El-Gohary YM, Metwally G, Saad RS, Robinson MJ, Mesko T, Poppiti RJ. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am J Clin Pathol 2008, 129(4):578-586.
7. Karadayι N, Kandemιr NO, Yavuzer D, Korkmaz T, Gecmen G, Kokturk F. Inducible nitric oxide synthase expression in gastric adenocarcinoma: impact on lymphangiogenesis and lymphatic metastasis. Diagn Pathol 2013, 8:151.
8. Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg 2004, 240(2):306.
9. Valencak J, Heere-Ress E, Kopp T, Schoppmann S, Kittler H, Pehamberger H. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer 2004, 40(3):358-364.
10. Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I, Ostoros G, Agocs L, Soltesz I, Dome B. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Canc Res 2005, 11(20):7344-7353.
11. Takanami I. Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer. Oncol Rep 2006, 15(2):437-442.
12. Zorgetto VA, Silveira GG, Oliveira-Costa JP, Soave DF, Soares FA, Ribeiro-Silva A. The relationship between lymphatic vascular density and vascular endothelial growth factor A (VEGF-A) expression with clinical-pathological features and survival in pancreatic adenocarcinomas. Diagn Pathol 2013, 8(1):170.
13. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15(2):290.
14. Chen J-C, Chang Y-W, Hong C-C, Yu Y-H, Su J-L. The role of the VEGF-C/VEGFRs axis in tumor progression and therapy. Int J Mol Sci 2012, 14(1):88-107.
15. Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Canc Res Treat 2001, 66(2):159-164.
16. Cai X, Ma S, Gu M, Zu C, Qu W, Zheng X. Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Diagn Pathol 2012, 7(1):1-8.
17. Kigure W, Fujii T, Sutoh T, Morita H, Katoh T, Yajima R, Yamaguchi S, Tsutsumi S, Asao T, Kuwano H. The Association of VEGF-C expression with tumor lymphatic vessel density and lymph node metastasis in patients with gastric cancer and gastrointestinal stromal tumor. Hepatogastroenterology 2012, 60(122):277-280.
18. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 2003, 97(2):457-464.
19. Cao Y. Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis. Cell Cycle 2005, 4(2):231-233.
20. Heldin C-H, Eriksson U, Östman A. New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 2002, 398(2):284-290.
21. Cao Y. Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Canc 2005, 5(9):735-743.
22. Onimaru M, Yonemitsu Y, Fujii T, Tanii M, Nakano T, Nakagawa K, Kohno R-I, Hasegawa M, Nishikawa S-I, Sueishi K. VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B. Am J Physiol Heart Circ Physiol 2009, 297(5):H1685-H1696.
23. Matsumoto S, Yamada Y, Narikiyo M, Ueno M, Tamaki H, Miki K, Wakatsuki K, Enomoto K, Yokotani T, Nakajima Y. Prognostic significance of platelet-derived growth factor-BB expression in human esophageal squamous cell carcinomas. Anticancer Res 2007, 27(4B):2409-2414.
24. Donnem T, Al-Saad S, Al-Shibli K, Busund L-T, Bremnes R. Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer. Ann Oncol 2010, 21(2):223-231.
25. Fleming ID, Phillips JL, Menck HR, Murphy GP, Winchester DP. The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM staging. Cancer 1997, 80(12):2305-2310.
26. Hensing TA. Clinical evaluation and staging of patients who have lung cancer. Hematol Oncol Clin North Am 2005, 19(2):219-235.
27. Hasina R, Whipple ME, Martin LE, Kuo WP, Ohno-Machado L, Lingen MW. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Lab Investig 2008, 88(4):342-353.
28. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med 1991, 324(1):1-8.
29. Fidler IJ. The pathogenesis of cancer metastasis: the'seed and soil'hypothesis revisited. Nat Rev Canc 2003, 3(6):453-458.
30. Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt R, Hantusch B. Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Investig 2011, 121(5):2000.
31. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK. Cancer cells compress intratumour vessels. Nature 2004, 427(6976):695.
32. Bono P, Wasenius V-M, Heikkilä P, Lundin J, Jackson DG, Joensuu H. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Canc Res 2004, 10(21):7144-7149.
33. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002, 296(5574):1883-1886.
34. Cao R, Björndahl MA, Religa P, Clasper S, Garvin S, Galter D, Meister B, Ikomi F, Tritsaris K, Dissing S. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004, 6(4):333-345.
35. Schoppmann SF, Alidzanovic L, Schultheis A, Perkmann T, Brostjan C, Birner P. Thrombocytes correlate with lymphangiogenesis in human esophageal cancer and mediate growth of lymphatic endothelial cells in vitro. PLoS One 2013, 8(6):e66941.
36. Shibuya M. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis A Crucial Target for Anti-and Pro-Angiogenic Therapies. Genes Canc 2011, 2(12):1097-1105.